Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q80XC6

Entry ID Method Resolution Chain Position Source
AF-Q80XC6-F1 Predicted AlphaFoldDB

79 variants for Q80XC6

Variant ID(s) Position Change Description Diseaes Association Provenance
rs251072869 19 F>S No EVA
rs49177424 29 P>S No EVA
rs218712451 46 V>A No EVA
rs253996368 55 P>L No EVA
rs226355115 63 R>W No EVA
rs3403644430 72 G>A No EVA
rs3403614619 72 G>R No EVA
rs216350176 75 N>D No EVA
rs256946735 82 Q>H No EVA
rs231964824 83 T>I No EVA
rs3389269413 105 R>K No EVA
rs45859201 110 L>S No EVA
rs242933879 113 S>N No EVA
rs3389258542 115 S>Y No EVA
rs223389279 121 A>P No EVA
rs3389228477 176 K>M No EVA
rs3389251634 194 R>S No EVA
rs3389250520 196 K>N No EVA
rs3389228557 236 N>* No EVA
rs3389264651 236 N>S No EVA
rs3389264652 238 G>E No EVA
rs3389248093 241 R>G No EVA
rs3389187219 245 I>T No EVA
rs3389255429 249 S>C No EVA
rs249452124 249 S>T No EVA
rs3389264706 260 T>I No EVA
rs3389269370 261 F>I No EVA
rs3389255465 277 W>R No EVA
rs6341175 332 W>R No EVA
rs3403753082 369 K>* No EVA
rs3389263449 393 K>R No EVA
rs3389256671 444 S>P No EVA
rs3389255415 445 K>I No EVA
rs220807878 447 H>L No EVA
rs3389251643 448 S>R No EVA
rs3389187220 480 G>R No EVA
rs3389255403 496 E>K No EVA
rs3389263414 516 V>M No EVA
rs234542343 535 G>R No EVA
rs234787660 562 I>V No EVA
rs3389213899 569 E>K No EVA
rs245090336 594 R>H No EVA
rs3389248160 600 H>N No EVA
rs3389222862 606 P>L No EVA
rs3389256728 624 V>M No EVA
rs3389251694 635 R>K No EVA
rs3389240378 638 S>I No EVA
rs3389263482 684 K>R No EVA
rs3389248166 687 T>I No EVA
rs3389252818 693 F>L No EVA
rs6238974 707 R>C No EVA
rs387905415 707 R>H No EVA
rs3403807523 709 R>L No EVA
rs3402918205 712 K>* No EVA
rs3403807563 712 K>I No EVA
rs3403637690 715 N>S No EVA
rs3389264673 716 R>* No EVA
rs6238859 733 L>F No EVA
rs387370555 741 L>V No EVA
rs260101861 742 S>C No EVA
rs3389256698 754 I>F No EVA
rs3389256702 760 K>* No EVA
rs3389222828 764 L>S No EVA
rs246644070 770 S>N No EVA
rs3389228545 790 L>I No EVA
rs3403947415 866 P>V* No EVA
rs237074706 868 G>R No EVA
rs3389264729 898 C>R No EVA
rs3389248091 899 A>G No EVA
rs254426146 903 A>V No EVA
rs3389264670 910 C>S No EVA
rs3389187250 966 L>F No EVA
rs3389228538 1016 Q>H No EVA
rs3389187213 1023 N>K No EVA
rs3389213930 1037 K>I No EVA
rs3389269446 1095 Q>L No EVA
rs3389240385 1097 P>L No EVA
rs3402268513 1110 L>* No EVA
rs247445707 1172 D>G No EVA

No associated diseases with Q80XC6

5 regional properties for Q80XC6

Type Name Position InterPro Accession
repeat HAT (Half-A-TPR) repeat 404 - 436 IPR003107-1
repeat HAT (Half-A-TPR) repeat 765 - 800 IPR003107-2
repeat HAT (Half-A-TPR) repeat 802 - 841 IPR003107-3
repeat HAT (Half-A-TPR) repeat 1075 - 1109 IPR003107-4
repeat HAT (Half-A-TPR) repeat 1111 - 1143 IPR003107-5

Functions

Description
EC Number
Subcellular Localization
  • Nucleus speckle
  • Nucleus, nucleolus
  • Nucleus, nucleoplasm
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleolus A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

8 GO annotations of biological process

Name Definition
cell division The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
cellular response to DNA damage stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism.
mitotic cell cycle Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent.
mRNA processing Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.
negative regulation of RNA catabolic process Any process that stops, prevents or reduces the frequency, rate or extent of RNA catabolic process.
positive regulation of RNA export from nucleus Any process that activates or increases the frequency, rate or extent of directed movement of RNA from the nucleus into the cytoplasm.
post-transcriptional gene silencing by RNA A posttranscriptional gene silencing pathway in which regulatory RNAs elicit silencing of specific target genes, either by mRNA destabilization or inhibition of translation.
RNA splicing The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.

2 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9H7Z3 NRDE2 Nuclear exosome regulator NRDE2 Homo sapiens (Human) PR
G5EG51 nrde-2 Nuclear exosome regulator NRDE2 Caenorhabditis elegans PR
10 20 30 40 50 60
MALFPAFADV SEASGDGAFR KELDWLSNPS FRVGNLTSLS RQTEEVTALA SEGSPPPRYS
70 80 90 100 110 120
FIRSPLKSEL SGESNTSEKL AQTSRKKKKE KKKRRKHQHH RKTKRRHEQL SSSGSESDTE
130 140 150 160 170 180
AGKDRASRSI RDDQKEAEKP CQGSNAAAAV AAAAGHRSIW LEDIHDLTDV FRTDKKPDPA
190 200 210 220 230 240
NWEYKSLYRG DIARYKRKGD SCLGINPKKQ CISWEGASAA KKHSHRHLER YFTKKNVGLM
250 260 270 280 290 300
RTEGIAVCSN PEPASSEPVT FIPVKDSAEA ATPVTSWLNP LGIYDQSTTQ WLQGQGPAEQ
310 320 330 340 350 360
ESKQPDSQQD RENAALKARV EEFNRRVREN PWDTQLWMAF VAFQDEVMRS PGIYALGEGE
370 380 390 400 410 420
QEKHRKSLKL LLEKKLAVLE RAIESNPGSV ELKLAKLQLC SEFWEPSALA KEWQKLLFLH
430 440 450 460 470 480
PNNTSLWQRY LSFCQSQFGT FSVSKLHSLY GKCLSTLSAV KDGSMLSHPV LPGTEEAMFG
490 500 510 520 530 540
LFLQQCHFLR QAGHSEKVIS LFQAMVDFTF FKPDSVKELP TKVQVEFFEP FWDSGEPRVG
550 560 570 580 590 600
EKGARGWRAW MHQQERGGWV LITPDEDDEE PEEEDQEIKD KTLPRWQIWL AVERSRDQRH
610 620 630 640 650 660
WRPWRPDKTK KQTEEDCEDP ERQVLFDDIG QSLIRLSSPD LQFQLIQAFL QFLGVPSGFL
670 680 690 700 710 720
PPASCLYLAM DESSIFESEL YDEKPLTYFN PSFSGISCVG SMEQLGRPRW TKGHNREGEE
730 740 750 760 770 780
FVRNVFHLVL PLLAGKQKSQ LSLSWLRYEI AKVIWCLHTK KKRLKSQGKS CKKLAKNLLK
790 800 810 820 830 840
EPENRNNFCL WKQYAHLEWL LGNTEDARKV FDTALSMAGS SELKDRELCE LSLLYAELEM
850 860 870 880 890 900
ELSPDSRGAT TGRAVHILTR LTESSPYGPY TGQVSSTQVL KARKAYELAL QDCLGQSCAS
910 920 930 940 950 960
SPAPAEALDC LGSLVRCFML FQYLTVGIDA AVQIYGRVFA KLKGSARLED PGPEDSTSSQ
970 980 990 1000 1010 1020
SLTNVLEAVS MMHTSLLRFH MNVCVYPLAP LRETLSDALK LYPGNQVLWR AYVQIQNKSH
1030 1040 1050 1060 1070 1080
SANKTRRFFD TVTRSAKHLE PWLFAIEAEK LRKKLVESVQ RVGGREVHAT IPETGLTHRI
1090 1100 1110 1120 1130 1140
RALFENAIRS DKGNQCPLLW RMYLNFLVSL GNKERSKGVF YKALQSCPWA KVLYMDAMEY
1150 1160 1170
FPDELQEILD VMTEKELRVR LPLEELELLL ED